Salvigenin impedes aerobic glycolysis and enhances sensitivity to 5-fluorouracil(5-FU) in HCC cells by inhibiting the PI3K/AKT/GSK-3β pathway, restraining tumor growth in nude mice and promoting apoptosis (86). This evidence concerns the gene AKT1 and hepatocellular carcinoma.